Drug Profile
Research programme: small molecule galectin-3 inhibitors - Galectin Sciences
Alternative Names: Galectin 3 inhibitors - Galectin SciencesLatest Information Update: 28 Apr 2022
Price :
$50
*
At a glance
- Originator Galectin Sciences
- Class Antifibrotics; Antineoplastics; Small molecules
- Mechanism of Action Galectin 3 inhibitors; Galectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Fibrosis
Most Recent Events
- 28 Apr 2022 No recent reports of development identified for research development in Cancer in USA (PO)
- 28 Apr 2022 No recent reports of development identified for research development in Fibrosis in USA (PO)
- 20 Apr 2020 Early research is still ongoing for Fibrosis and Cancer in USA (PO) (Galectin Therapeutics pipeline, April 2020)